ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Financial Statements

280 Followers

ARS Pharmaceuticals Financial Overview

ARS Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.465; its P/E ratio is -27.80; ARS Pharmaceuticals is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 500.00K---$ 10.00K
Gross Profit$ 500.00K---$ 10.00K
EBIT$ -15.34M$ -13.19M$ -10.23M$ -14.87M$ -17.37M
EBITDA$ -15.34M$ -13.19M$ -10.23M-$ -19.10M
Net Income Common Stockholders$ -12.52M$ -10.29M$ -7.17M$ -14.87M$ -17.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 218.74M$ 223.63M$ 228.36M$ 241.90M$ 252.21M
Total Assets$ 221.97M$ 227.58M$ 233.19M$ 248.56M$ 258.75M
Total Debt$ 160.00K$ 217.00K$ 274.00K$ 327.00K$ 379.00K
Net Debt$ -218.58M$ -223.41M$ -228.09M$ -241.57M$ -251.83M
Total Liabilities$ 6.72M$ 3.71M$ 2.43M$ 11.27M$ 10.20M
Stockholders Equity$ 215.24M$ 223.87M$ 230.76M$ 237.28M$ 248.55M
Cash Flow-
Free Cash Flow$ -7.32M$ -6.79M$ -17.31M-$ -16.70M
Operating Cash Flow$ -7.28M$ -6.71M$ -17.41M$ -12.76M$ -16.67M
Investing Cash Flow$ -12.65M$ -8.51M$ 26.04M$ -46.64M$ 44.97M
Financing Cash Flow$ 545.00K$ 258.00K$ 1.80M$ 921.00K$ 2.85M
Currency in USD

ARS Pharmaceuticals Earnings and Revenue History

ARS Pharmaceuticals Debt to Assets

ARS Pharmaceuticals Cash Flow

ARS Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis